PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsAmchafibrin
Amchafibrin
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
710 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
HemorrhageD006470MP_0001914R582248738588297
Postpartum hemorrhageD006473—O7251218111858
Surgical blood lossD016063——6818171257
Postoperative hemorrhageD019106——4610101038
Bone fracturesD050723EFO_0003931T14.8227131034
Knee osteoarthritisD020370EFO_0004616M17—42101430
OsteoarthritisD010003EFO_0002506M15-M1915561329
Hip fracturesD006620EFO_0003964S72.001379726
MelanosisD008548HP_0001480L81.143531023
MenorrhagiaD008595EFO_0003945N92.02166721
Show 154 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Brain injuriesD001930—S06.9136——9
Traumatic brain injuriesD000070642—S06126——8
HemoptysisD006469HP_0002105R04.2——4—26
Covid-19D000086382———31—15
Von willebrand diseasesD014842EFO_0003910D68.0——2—35
SepsisD018805HP_0100806A41.9—12—14
SeizuresD012640HP_0002069G40.4——2—24
Hematologic neoplasmsD019337———13——4
ShockD012769—R57.1—31——4
Hereditary hemorrhagic telangiectasiaD013683—I78.0—12——3
Show 56 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Skin neoplasmsD012878EFO_0004198C4411——13
High-risk pregnancyD018566———1——12
Intervertebral disc degenerationD055959HP_0008419——1——12
ErythemaD004890HP_0010783L53.9—1——12
Multiple traumaD009104—T0711——12
Surgical woundD000072836———1——12
Neoplasm metastasisD009362EFO_0009708—11——12
Operative surgical proceduresD013514———1———1
Pathologic dilatationD004108———1———1
Urinary retentionD016055HP_0000016R3311———1
Show 19 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Knee prosthesisD007720——1———12
Back painD001416HP_0003418M541————1
Tendon injuriesD013708——1————1
IleusD045823——1————1
Tissue adhesionsD000267——1————1
Hip osteoarthritisD015207EFO_1000786M161————1
GynecomastiaD006177HP_0000771N621————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
FibrinolysisD005342——————77
HemostasisD006487——————33
Heart failureD006333HP_0001635I50————22
PainD010146EFO_0003843R52————22
HyperaldosteronismD006929HP_0011736E26————22
Pulmonary arterial hypertensionD000081029——————22
Urinary tract infectionsD014552EFO_0003103N39.0————22
HypokalemiaD007008HP_0002900E87.6————22
Sleep initiation and maintenance disordersD007319—F51.01————22
Cardiac arrhythmiasD001145EFO_0004269I49.9————22
Show 123 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name—
INN—
Description
—
Classification
Unknown
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL ID—
ChEBI ID—
PubChem CID—
DrugBank—
UNII ID—
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use